CSCO expert consensus on the diagnosis and treatment of breast cancer brain metastasis

Zefei Jiang, Yingwei Mao(Suizhou Central Hospital), Tao Jiang(Ocean University of China), Minjie Fu(Fudan University), Yueping Liu(Hebei Medical University), Min Yan(Zhengzhou University), Wei Hua(Sichuan University), Yang Jin(Guiyang Medical University), Jiaxin Chen(Ruijin Hospital), Jiayi Chen(Beijing Normal University), Jia Wang(Hebei Medical University), Juan Zhou(Nanjing Medical University), Dan Ou(Fudan University Shanghai Cancer Center), Chunfang Hao(The Fourth People's Hospital of Ningxia Hui Autonomous Region), Biyun Wang(Fudan University Shanghai Cancer Center), Tao Wang(Kunming University of Science and Technology)
Translational Breast Cancer Research
July 1, 2022
10.21037/tbcr-22-30
Cited by 12

Related Papers

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
|Annals of Oncology|2021|799
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400